APOE ε4 allele modifies the association of lead exposure with age-related cognitive decline in older individuals.

[1]  A. Algra,et al.  The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease. , 2016, Atherosclerosis.

[2]  E. Colicino,et al.  Influence of multiple APOE genetic variants on cognitive function in a cohort of older men – results from the Normative Aging Study , 2014, BMC Psychiatry.

[3]  I. Rosset,et al.  Global Epidemiology of Dementia: Alzheimer's and Vascular Types , 2014, BioMed research international.

[4]  J. Schwartz,et al.  Lead exposure and rate of change in cognitive function in older women. , 2014, Environmental research.

[5]  M. Greicius,et al.  Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction , 2013, Brain Imaging and Behavior.

[6]  J. Schwartz,et al.  Modification by hemochromatosis gene polymorphisms of the association between traffic-related air pollution and cognition in older men: a cohort study , 2013, Environmental Health.

[7]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[8]  P. Vokonas,et al.  Longitudinal Changes in Bone Lead Levels: The VA Normative Aging Study , 2011, Journal of occupational and environmental medicine.

[9]  T. Lehtimäki,et al.  The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks. , 2011, Metabolism: clinical and experimental.

[10]  Gerald van Belle,et al.  Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years , 2008, Alzheimer's & Dementia.

[11]  D. Cory-Slechta,et al.  New and Evolving Concepts in the Neurotoxicology of Lead , 2007 .

[12]  Annette Ashizawa,et al.  Toxicological Profile for Lead , 2007 .

[13]  J. Schwartz,et al.  Modifying Effects of the HFE Polymorphisms on the Association between Lead Burden and Cognitive Decline , 2007, Environmental health perspectives.

[14]  A. Spiro,et al.  Cumulative Lead Exposure and Cognitive Performance Among Elderly Men , 2007, Epidemiology.

[15]  Jonas Persson,et al.  Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers , 2006 .

[16]  A. Spiro,et al.  Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. , 2004, American journal of epidemiology.

[17]  B. Winblad,et al.  Risk and protective effects of the APOE gene towards Alzheimer’s disease in the Kungsholmen project: variation by age and sex , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  Anne Spurgeon,et al.  Recent Developments in Low-Level Lead Exposure and Intellectual Impairment in Children , 2004, Environmental health perspectives.

[19]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Spiro,et al.  Lead Exposure Biomarkers and Mini-Mental Status Exam Scores in Older Men , 2003, Epidemiology.

[21]  David Simon,et al.  ApoE genotype, past adult lead exposure, and neurobehavioral function. , 2002, Environmental health perspectives.

[22]  Howard Hu,et al.  Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. , 1998, Environmental health perspectives.

[23]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[24]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[25]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[26]  S. Wilton,et al.  Apolipoprotein E and Alzheimer's disease , 1995 .

[27]  F. V. Bockxmeer.  Apolipoprotein E and Alzheimer's , 1995, Nature.

[28]  M. Jetté,et al.  Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity , 1990, Clinical cardiology.

[29]  G. Assmann,et al.  Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1). , 1990, Journal of lipid research.

[30]  D. Wechsler,et al.  The psychometric tradition: Developing the wechsler adult intelligence scale☆ , 1981 .

[31]  B. Bell,et al.  The Veterans Administration longitudinal study of healthy aging. , 1966, The Gerontologist.